Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial

The Lancet 2026

View at publisher
Authors: Vanita R. Aroda, Melanie J Davies, Jill Maaske, Marcus Millegård, Víctor López Juan, Jens Aberle, Andreea Ciudin, Rory J. McCrimmon, Olof Eklund, Judy L. Shih, Mikaela Sjöstrand, Donna Zarzuela
+1 more Julio Rosenstock
DOI: 10.1016/s0140-6736(26)00802-0
Cited by: 1
References: 14

Fields of Study & Subjects

Diabetes Treatment and Management Pancreatic function and diabetes Regulation of Appetite and Obesity

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
407
Issue
10547
Pages
2515–2527
Publication date
1 June 2026
Language
EN